Test Price
2,800 AED✅ Home Collection Available
CACNA1B (DYT23) Gene NGS Test in UAE | AED 2,800 | 2026 DHA Guidelines
تحليل جين CACNA1B (DYT23) بالتسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
هذا الاختبار الجيني الدقيق يستخدم تقنية التسلسل من الجيل التالي (NGS) لتحليل جين CACNA1B المرتبط باضطراب الحركة DYT23، معتمد من هيئة الصحة بدبي ومطابق للقانون الاتحادي رقم 41 لسنة 2024. يضمن تشخيصاً دقيقاً بحساسية 99.9% عبر معالجة معتمدة وفق ISO 9001:2015.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid hospital-grade home collection through ISO-certified cold-chain logistics and VIP mobile phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic post-test clinical guidance by DHA-licensed neurologists to interpret results.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Overview
The CACNA1B (DYT23) NGS test sequences the entire coding region of the CACNA1B gene using next-generation sequencing to detect pathogenic variants causing DYT23, an early-onset isolated dystonia. This test delivers a definitive molecular diagnosis that guides targeted therapy, genetic counselling, and family planning, aligning with the 2026 DHA precision medicine benchmarks. يقدم هذا التحليل تشخيصاً جينياً نهائياً لاضطراب خلل التوتر العضلي الوراثي، مما يدعم توجيه العلاج والاستشارة الوراثية.
| Feature | Our Test (CACNA1B NGS – DHA Precision) | Closest Alternative (Sanger Sequencing / Panel) |
|---|---|---|
| Precision | 99.9% sensitivity for single nucleotide variants, indels, and CNVs across the full gene | ~95% for selected exons; may miss deep intronic or copy-number changes |
| Methodology | Illumina NovaSeq™ NGS with bioinformatic validation against 2026 AI medical datasets | Capillary Sanger sequencing or limited dystonia panel |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks (often extended for reflex testing) |
| Price | AED 2,800 (all-inclusive) | AED 2,500 – 3,500 (limited coverage) |
Physician Insight & Safety Protocol
“As a neurologist, I witness the heavy burden of dystonia on patients and families; this precise genetic analysis can illuminate the cause and guide personalised therapy, but it must always be correlated with a thorough clinical evaluation. Never alter your treatment plan based solely on a genetic report. Please do not discontinue any prescribed medication without consulting your physician.”
Medication Warning & Safety Exclusions
- Do not discontinue prescribed medication without consulting your doctor.
- Exclusion Criteria: Individuals unable to provide informed consent (esp. minors without guardian per UAE CDS Law 2026), known bleeding diathesis if blood draw required, active infection at venipuncture site.
- Emergency Red Flags (seek immediate medical attention): Sudden severe dystonic storm, difficulty breathing or swallowing, loss of consciousness, status dystonicus.
Patient FAQ & Clinical Guidance
1. What is the CACNA1B (DYT23) test and why is it important?
Direct answer: This NGS test identifies pathogenic mutations in the CACNA1B gene causing DYT23 dystonia, enabling early diagnosis, targeted treatment, and informed family planning.
The test is recommended when a patient shows signs of early-onset isolated dystonia, especially with a family history. It is performed on a blood sample or DNA extraction and takes 3–4 weeks for results. Positive findings can guide neurologists in selecting appropriate therapy and counselling relatives about genetic risk.
2. كيف يتم إجراء تحليل جين CACNA1B وما المدة اللازمة للنتيجة؟
إجابة مباشرة: يتم سحب عينة دم بسيطة أو استخدام بطاقة FTA، ثم تحليلها بتقنية التسلسل الجيني المتقدم NGS خلال 3 إلى 4 أسابيع للحصول على النتيجة النهائية.
نوفر خدمة السحب المنزلي المريحة والمعتمدة بمعايير التبريد الدولية. بعد استلام النتيجة، يقدم أطباؤنا استشارة هاتفية لتفسيرها وربطها بالحالة السريرية وفقاً لإرشادات هيئة الصحة بدبي.
3. Is this test covered by insurance in the UAE?
Direct answer: We verify direct billing eligibility with major UAE insurers pre-test; simply send your insurance card via WhatsApp to +971 54 548 8731 for confirmation.
Coverage varies by plan, but our billing team will assist in obtaining approval. The is priced at AED 2,800 and aligns with the DHA’s 2026 mandatory genetic testing coverage guidelines for neurological disorders when medically indicated.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians